Outlook Therapeutics said on Wednesday the U.S. health regulator has declined to approve its drug for a type of eye disease, ...

Outlook Therapeutics said on Wednesday the U.S. health regulator has declined to approve its drug for a type of eye disease, ...

The FDA granted priority review to veligrotug for the treatment of thyroid eye disease, according to a press release from ...

(Reuters) -Viridian Therapeutics said on Tuesday its experimental treatment helped significantly reduce symptoms of thyroid eye disease (TED) in a late-stage study, setting the stage to become the ...

FDA approvals in 2025 introduced novel therapies and devices across ophthalmic subspecialties, emphasizing sustained efficacy ...

A panelist discusses how dry eye disease involves tear film imbalance, leading to inflammation and ocular surface damage, emphasizing the importance of precise diagnosis and tailored treatment while ...

Tarsus Pharma has a drug for Demodex blepharitis and multiple late-stage assets in its pipeline, including lotilaner for various formulations. The company has seen a 65% increase in stock value, with ...

Thyroid eye disease is a chronic autoimmune disorder causing inflammation in the muscles and other tissues behind the eye. It can lead to other eye complications, including glaucoma. Thyroid eye ...

Credit: Alcon. Access initiatives including a First Fill Free trial program and an ongoing copay support will be available for eligible patients. The active ingredient in Tryptyr is acoltremon, an ...

Dry eye disease affects millions of people, causing burning, redness, and constant eye fatigue that can worsen over time. Scientists now believe the problem may begin deep inside tear glands, where a ...

Dry eye disease is a condition that occurs when your eyes do not make enough tears or when your tears dry up too quickly. Tears are essential for keeping the surface of your eyes healthy, comfortable, ...

Nandita Vijayasimha, Bengaluru Friday, January 2, 2026, 09:00 Hrs [IST] ...